Package 72485-221-02

Brand: gemcitabine

Generic: gemcitabine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72485-221-02
Digits Only 7248522102
Product NDC 72485-221
Product ID 72485-221_52a15e83-e33d-42e7-9270-636b5b59d63b
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (72485-221-02) / 5.26 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2020-01-15
Brand gemcitabine
Generic gemcitabine hydrochloride
Sample Package No

Linked Drug Pages (1)

Gemcitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "52a15e83-e33d-42e7-9270-636b5b59d63b", "openfda": {"upc": ["0372485221028"], "unii": ["U347PV74IL"], "rxcui": ["1720977"], "spl_set_id": ["57b80f66-208d-4903-9443-e4c9239e3207"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (72485-221-02)  / 5.26 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "72485-221-02", "marketing_start_date": "20200115"}], "brand_name": "Gemcitabine", "product_id": "72485-221_52a15e83-e33d-42e7-9270-636b5b59d63b", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "72485-221", "generic_name": "GEMCITABINE HYDROCHLORIDE", "labeler_name": "Armas Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gemcitabine", "active_ingredients": [{"name": "GEMCITABINE HYDROCHLORIDE", "strength": "200 mg/5.26mL"}], "application_number": "ANDA210991", "marketing_category": "ANDA", "marketing_start_date": "20200115", "listing_expiration_date": "20261231"}